Efficient inhibition of HIV-1 aspartic protease by synthetic, computer designed peptide mimetics

Minerva Biotecnologica

Volumn 8, Issue 3, 1996, Pages 165-171

  Tossi, Alessandro ^a   Furlan, Michela ^b   Antcheva, Nikolinka ^a   Romeo, Domenico ^a   Miertus, Stanislav ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Area Science Park

Author keywords

Aspartic protease; Drug design; HIV 1; Peptides, chemical synthesis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1542706596     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Stone D. HIV protease inhibitors head to market. Biotechnol. 1995;13:941-2.
2. Wlodawer A, Erickon JW. Structure-based inhibitors of HIV-1 Protease. Ann Rev Biochem 1993;62:543-85.
3. Richman DD. Protease uninhibited. Nature 1995;374:494.
4. Vacca JP. Design of tight-binding human immunodeficiency virus Type 1 protease inhibitors. Methods Enzymol 1994; 241:311-34.
5. Miller M, Schneider J, Sarhyanarayana BK, Toth MV, Marshall GR, Clawson L et al. Structure of a complex of synthetic HIV-1 protease with a structure-based inhibitor at 2.3Å. Science 1989;246:1149-52.
6. Miertus S, Furlan M, Tossi A, Romeo D. Design of new inhibitors of HIV-1 aspartic protease. Chem Phys (in press).
7. Miertus S, Antcheva N, Tossi A, Bizik F, Benedetti F, Gennaro R et al. CADD of new pseudo-peptide inhibitors of HIV-1 aspartic protease. In: Sanz F, editor. QSAR and molecular modelling: concepts, computational tools and biological applications. JR Prous Barcelona (in press).
8. Miertus S, Frecer V. Continuum models of environmental effects on molecular structure and mechanisms in chemistry and biology. J Math Chem 1992;10:183-204.
9. Miertus S. Evaluation of complexation energies between the aspartic protease of HIV-1 and its hexapeptide inhibitors, including the effect of solvation. Bioorg and Med Chem Letters 1993;3:2105-12.
10. 2-NH reduced bond surrogate. In: Pennington MW, Dunn BM, editors. Methods in molecular biology. Volume 35. Peptide Synthesis Protocols. Humana Press 1994:241-7.
11. Fehrentz, JA, Castro B. An efficient synthesis of optically active α-(t-butoxycarbonylamino)-aldehydes from α-amino acids. Synthesis 1983;676-8.
12. Meek TD, Rodriguez EJ, Angeles TS. Use of steady state kinetic methods to elucidate the kinetic and chemical mechanisms of retroviral proteases. Meth Enzymol 1994;241:127-56.
13. Dunn BM, Gustchina A, Wlodawer A, Kay J. Subsite preferences of retroviral proteinases. Meth Enzymol 1994;241:255-78.
14. Condra JH, Scleif WA, Blahy OM, Gabryelski LJ, Graham DJ, Quintero JC et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 1995;374;569-71.